Open Orphan (LON:ORPH) Stock Price Up 5.3% – Here’s What Happened

Open Orphan Plc (LON:ORPH)’s stock price rose 5.3% during trading on Wednesday . The company traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.13). Approximately 652,639 shares changed hands during trading, a decline of 58% from the average daily volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).

Open Orphan Price Performance

The company has a current ratio of 1.19, a quick ratio of 1.16 and a debt-to-equity ratio of 10.88. The stock has a market capitalization of £67.09 million and a price-to-earnings ratio of -25.30. The stock has a 50-day moving average price of GBX 10 and a 200 day moving average price of GBX 10.

About Open Orphan

Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.